Insiders · Profile

Gupta Suneel

Chief Development Officer at Protagonist Therapeutics. Filing since 3 Dec 2019. CIK 0001763923

Company
Date
Role
Action
Shares
Amount
Of holding
26 Nov 2024
Chief Development Officer
Sold at will
19,191
$873.19K
6.7%
25 Nov 2024
Chief Development Officer
Sold at will
103,437
$4.76M
28.8%
9 Jan 2024
Chief Development Officer
Sold on a plan
5,000
$125.00K
2.6%
3 Dec 2019
EVP Clinical Operations
Bought
30,000
$153.90K
154%
4 decisions on file.